Last updated on March 2018

Neoadjuvant Chemotherapy in Epithelial Ovarian Cancer


Brief description of study

The purpose of this study is to define whether 6 courses of neoadjuvant chemotherapy can lead to a higher rate of complete cytoreductive surgery compared with 3 courses of neoadjuvant chemotherapy in patients with epithelial ovarian cancer, fallopian tube cancer or primary peritoneal cancer.

Clinical Study Identifier: NCT02125513

Find a site near you

Start Over